Search for: "Astrazeneca" Results 501 - 520 of 1,244
Sort by Relevance | Sort by Date
RSS Subscribe: 20 results | 100 results
30 Jul 2013, 1:34 pm by Ronald V. Miller, Jr.
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm by Ronald V. Miller, Jr.
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm by Ronald V. Miller, Jr.
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
30 Jul 2013, 1:34 pm by Ronald V. Miller, Jr.
In addition to the European agency, the Food and Drug Administration has been reviewing the safety of a big class of drugs that includes Januvia by Merck and the drugs Byetta, Bydureon and Onglyza, which are sold by Bristol-Myers Squibb and AstraZeneca. [read post]
28 Jul 2013, 9:29 am by Spencer Aronfeld
  Byetta, now sold by Bristol-Myers Squibb and AstraZeneca, was approved in 2005 and contained a warning about pancreatitis. [read post]
14 Jun 2013, 6:23 pm
Bristol-Myers said it and AstraZeneca Plc (AZN) have two such trials that will provide additional data on the pancreatic risks as well. [read post]
12 Jun 2013, 12:50 pm by Tom Lamb
The concerns relate to a number of widely prescribed GLP-1–based therapies, the 2 injectable GLP-1 agonists, exenatide (Byetta, Amylin/Lilly) and liraglutide (Victoza, Novo Nordisk), and the oral DPP-4 inhibitors sitagliptin, saxagliptin (Ongylza, AstraZeneca/Bristol-Myers Squibb), and linagliptin (Tradjenta, Boehringer Ingelheim/Lilly). [read post]
14 May 2013, 6:18 pm by Mark Zamora
Nexium, manufactured by AstraZeneca, is a proton pump inhibitor (PPI) prescribed for the treatment of heartburn, acid-reflux, and inflammation of the esophagus. [read post]
4 May 2013, 10:13 am
Onglyza (saxagliptin) was approved by the FDA in 2009 and is manufactured by Bristol-Myers Squibb and AstraZeneca. [read post]
21 Apr 2013, 1:42 am by Mark Summerfield
  In 1998 and 1999 he gave evidence on behalf of generic manufacturer Alphapharm Pty Ltd, in a dispute with originating pharmaceutical manufacturer Aktiebolaget Hässle (a member of the Astra group, now AstraZeneca) over a patent covering the compound omeprazole, better known as heartburn drug Prilosec (or, in some markets, Losec). [read post]
24 Mar 2013, 8:01 pm by Patent Docs
AstraZeneca AB et al. v. [read post]
19 Mar 2013, 8:15 pm by Madhulika Vishwanathan
For instance, Canadian federal circuit held that AstraZeneca’s extended release formulation patent on the popular anti-psychotic drug Seroquel XR is obvious to try, whereas in stark contrast the US federal circuit rejected claims of obviousness and upheld the validity of the same patent. [read post]
14 Mar 2013, 8:31 am
Several former patients who suffered bone fractures, says AboutLawsuits, are suing AstraZeneca, the manufacturer of Nexium, claiming that the company did not sufficiently warn consumers about the risks associated with long term use. [read post]
4 Mar 2013, 7:05 am by Mark Zamora
Glucagonlike peptide 1(GLP-1) therapies that include exenatide - marketed as Byetta by an alliance between Bristol-Myers Squibb and AstraZeneca - and sitagliptin - marketed as Januvia by Merck - have been linked to pancreatitis before in studies on animals and small groups of patients, said the study's lead author. [read post]
27 Feb 2013, 9:53 pm by Aaron Barkoff
  Rather, the jurisdiction standard applied by Judge Sheridan (from AstraZeneca Pharm. [read post]